3D Bioprinting Breakthroughs: Innovations in Pharmaceutical and Biomedical Applications

Abstract The pharmaceutical sector is rapidly evolving by the advancements in 3D bioprinting technologies which extend traditional 3D printing into biologically relevant applications. These innovations enable the fabrication of multi-cellular tissues, patient-specific medical devices, tailored drug delivery systems, and customized pharmaceuticals, marking a transformative leap toward precision medicine. This review highlights the progress, challenges, materials limitations, and emerging applications of 3D bioprinting in pharmaceutical and biomedical research. Recent developments have facilitated the creation of personalized dosage forms, multi-drug polypills, and controlled-release formulations, alongside biomimetic tissue models for drug screening and regenerative therapies. Despite its promise, widespread clinical translation remains constrained by scalability, regulatory hurdles, material limitations, and quality control concerns. Integrating artificial intelligence, novel biomaterials, and multi-material printing is accelerating innovation, while addressing long-term stability and biocompatibility challenges. As 3D bioprinting continues to evolve, its convergence with digital health technologies is poised to redefine pharmaceutical manufacturing, enhance therapeutic outcomes, and advance patient-centered healthcare.